Elevated levels of ALPK1 expression were associated with heightened infiltration of immune cells in several cancer types, indicating its potential significance in modulating the immune microenvironment of gliomas and positioning it as a promising target for forthcoming immunotherapeutic strategies. The gene discussed is ALPK1; the disease is cancer.